Guidelines for the salvage therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2], Sargun Singh Walia M.B.B.S.[3]

Peptic ulcer Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Peptic Ulcer from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Upper GI Endoscopy
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery Endoscopic management Surgical management
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
2017 ACG Guidelines for Peptic Ulcer Disease
Guidelines for the Indications to Test for, and to Treat, H. pylori Infection
Guidelines for First line Treatment Strategies of Peptic Ulcer Disease for Providers in North America
Guidlines for factors that predict the successful eradication when treating H. pylori infection
Guidelines to document H. pylori antimicrobial resistance in the North America
Guidelines for evaluation and testing of H. pylori antibiotic resistance
Guidelines for when to test for treatment success after H. pylori eradication therapy
Guidelines for penicillin allergy in patients with H. pylori infection
Guidelines for the salvage therapy
Guidelines for the salvage therapy On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Guidelines for the salvage therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Guidelines for the salvage therapy
CDC on Guidelines for the salvage therapy
Guidelines for the salvage therapy in the news
Blogs on Guidelines for the salvage therapy
to Hospitals Treating Peptic ulcer
Risk calculators and risk factors for Guidelines for the salvage therapy

2017 ACG Guidelines for salvage therapy of peptic ulcer disease

Strong recommendation

In patients with persistent H. pylori infection, every effort should be made to avoid antibiotics that have been previously taken by the patient.

The following regimens can be considered for use as salvage treatment: 1.Bismuth quadruple therapy for 14 days is a recommended salvage regimen. 2.Levofloxacin triple regimen for 14 days is a recommended salvage regimen.

Conditional recommendation

Bismuth quadruple therapy or levofloxacin salvage regimens are the preferred treatment options if a patient received a first-line treatment containing clarithromycin. Selection of best salvage regimen should be directed by local antimicrobial resistance data and the patient’s previous exposure to antibiotics.

Clarithromycin or levofloxacin-containing salvage regimens are the preferred treatment options, if a patient received first-line bismuth quadruple therapy. Selection of best salvage regimen should be directed by local antimicrobial resistance data and the patient’s previous exposure to antibiotics.

The following regimens can be considered for use as salvage treatment: 1.Concomitant therapy for 10–14 days is a suggested salvage regimen. 2.Clarithromycin triple therapy should be avoided as a salvage regimen. 3.Rifabutin triple regimen consisting of a PPI, amoxicillin, and rifabutin for 10 days is a suggested salvage regimen. 4.High-dose dual therapy consisting of a PPI and amoxicillin for 14 days is a suggested salvage regimen.